However, in another study, although SGLT2 expression was found in human lung cancer tissues and cell lines, and in vitro experiments showed that canagliflozin attenuated lung cancer cell proliferation and DNA synthesis by inhibiting cell cycle progression, no reduction in tumor growth was found in in vivo experiments (25). This evidence concerns the gene SLC5A2 and lung carcinoma.